Summit Therapeutics Inc. (SMMT)

NASDAQ: SMMT · IEX Real-Time Price · USD

7.54

-0.60 (-7.37%)

At close: Jul 2, 2024, 4:00 PM

7.56

+0.02 (0.27%)

After-hours: Jul 2, 2024, 7:57 PM EDT

Summit Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018 - 2014
Market Capitalization	5,293	1,829	856	263	387	51	Upgrade
Market Cap Growth	137.93%	113.79%	225.51%	-32.01%	653.29%	162.39%	Upgrade
Enterprise Value	5,233	1,749	726	194	321	-12	Upgrade
PE Ratio	20.67	-2.97	-10.86	-2.97	-7.34	-	Upgrade
PS Ratio	-	-	1213.64	145.30	449.56	-	Upgrade
PB Ratio	94.33	23.54	6.76	3.16	4.87	0.65	Upgrade
P/FCF Ratio	-31.03	-23.86	-20.27	-3.61	-7.97	-1.96	Upgrade
P/OCF Ratio	-30.98	-23.83	-20.58	-3.62	-8.04	-1.98	Upgrade
EV/Sales Ratio	-	-	1029.46	107.15	372.87	-	Upgrade
EV/EBITDA Ratio	-25.00	-2.85	-9.52	-2.25	-6.30	-	Upgrade
EV/EBIT Ratio	-24.63	-2.84	-9.21	-2.19	-6.06	-	Upgrade
EV/FCF Ratio	-30.52	-22.82	-17.20	-2.66	-6.61	0.44	Upgrade
Debt / Equity Ratio	2.48	1.37	4.10	0.03	0.01	0.01	Upgrade
Debt / EBITDA Ratio	-0.96	-0.17	-6.80	-0.03	-0.01	-	Upgrade
Debt / FCF Ratio	-1.17	-1.38	-12.29	-0.04	-0.01	-0.03	Upgrade
Quick Ratio	6.70	9.13	16.73	2.86	3.36	4.68	Upgrade
Current Ratio	6.97	9.30	16.93	3.80	4.41	5.78	Upgrade
Asset Turnover	0	0	0.00	0.01	0.01	-	Upgrade
Return on Equity (ROE)	-136.10%	-571.80%	-83.90%	-95.90%	-66.60%	-	Upgrade
Return on Assets (ROA)	-55.50%	-269.20%	-30.50%	-67.10%	-53.00%	-	Upgrade
Return on Capital (ROIC)	-74.73%	-331.71%	-11.17%	-100.14%	-66.56%	-	Upgrade
Earnings Yield	-2.19%	-33.62%	-9.21%	-33.71%	-13.63%	-	Upgrade
FCF Yield	-2.24%	-4.19%	-4.93%	-27.73%	-12.55%	-51.14%	Upgrade
Buyback Yield / Dilution	-85.58%	-220.50%	-46.78%	-89.45%	-116.73%	-87.15%	Upgrade
Total Shareholder Return	-85.58%	-220.50%	-46.78%	-89.45%	-116.73%	-87.15%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).